Goldstein Joseph L
- SEC CIK
- 0001225474
No open-market purchases or sales filed in the past year.
Current role at each company
- REGN Regeneron Pharmaceuticals, Inc.Directoras of Jan 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Goldstein Joseph L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 (view filing) | Jan 23 | 2 days | Goldstein Joseph LDirector | SSale | −2.71K | $950.00 | −$2.57M | −29.8%6.38K after | 10b5-1 |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Goldstein Joseph LDirector | SSale | −3.61K | $800.00 | −$2.89M | −36.6%6.25K after | |
| Apr 1, 2022 (view filing) | Mar 30 | 2 days | Goldstein Joseph LDirector | SSale | −2.43K | $700.00 | −$1.70M | −28.6%6.08K after | |
| Sep 13, 2021 (view filing) | Sep 10 | 3 days | Goldstein Joseph LDirector | SSale | −2.48K | $650.00 | −$1.61M | −29.6%5.89K after |